Literature DB >> 6142041

Insulin regulation of insulin-like growth factor action in rat hepatoma cells.

J H Heaton, N L Krett, J M Alvarez, T D Gelehrter, J A Romanus, M M Rechler.   

Abstract

We have reported previously that insulin causes a complete but reversible desensitization to insulin action in rat hepatoma HTC cells in tissue culture, and that this insulin resistance is mediated by postbinding mechanisms rather than receptor down-regulation (Heaton, J. H., and Gelehrter, T. D. (1981) J. Biol. Chem. 256, 12257-12262). We report here that insulin causes a similar desensitization to the induction of tyrosine aminotransferase by the insulin-like growth factors IGF-I and IGF-II isolated from human plasma, and by multiplication-stimulating activity, the rat homologue of IGF-II. The results of both competition-binding studies and affinity cross-linking experiments indicate that insulin-like growth factors (IGFs) bind primarily to IGF receptors rather than to insulin receptors. The low concentrations at which these factors induce transaminase is consistent with their acting primarily via IGF receptors. This is confirmed by experiments utilizing anti-insulin receptor antibody which both inhibits 125I-insulin binding and shifts the concentration dependence of insulin induction of tyrosine aminotransferase to the right. This same immunoglobulin does not inhibit 125I-multiplication-stimulating activity binding and only minimally inhibits 125I-IGF-I binding. Anti-insulin receptor antibody also does not significantly shift the concentration dependence for the IGFs, suggesting that IGFs induce transaminase by acting via IGF receptors. Although insulin down regulates insulin receptors, it does not decrease IGF-I or IGF-II binding. We conclude that insulin causes desensitization of HTC cells to IGFs by affecting a postbinding step in IGF action, which may be common to the actions of both insulin and insulin-like growth factors.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6142041

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Desensitization of the insulin receptor by antireceptor antibodies in vivo is blocked by treatment of mice with beta-adrenergic agonists.

Authors:  D Elias; M Rapoport; I R Cohen; Y Shechter
Journal:  J Clin Invest       Date:  1988-06       Impact factor: 14.808

2.  Insulin receptor down-regulation is linked to an insulin-induced postreceptor defect in the glucose transport system in rat adipocytes.

Authors:  W T Garvey; J M Olefsky; S Marshall
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

3.  Thrombin induction of plasminogen activator-inhibitor in cultured human endothelial cells.

Authors:  T D Gelehrter; R Sznycer-Laszuk
Journal:  J Clin Invest       Date:  1986-01       Impact factor: 14.808

4.  Characterisation of insulin-like growth factor I receptor in skeletal muscles of normal and insulin resistant subjects.

Authors:  N Livingston; T Pollare; H Lithell; P Arner
Journal:  Diabetologia       Date:  1988-12       Impact factor: 10.122

5.  Binding properties and biological potencies of insulin-like growth factors in L6 myoblasts.

Authors:  F J Ballard; L C Read; G L Francis; C J Bagley; J C Wallace
Journal:  Biochem J       Date:  1986-01-01       Impact factor: 3.857

6.  Insulin-like growth factor I binding in hepatocytes from human liver, human hepatoma, and normal, regenerating, and fetal rat liver.

Authors:  J F Caro; J Poulos; O Ittoop; W J Pories; E G Flickinger; M K Sinha
Journal:  J Clin Invest       Date:  1988-04       Impact factor: 14.808

7.  A reproducible method for the expansion of mouse CD8+ T lymphocytes.

Authors:  Mark D Lewis; Evy de Leenheer; Sigal Fishman; Lai Khai Siew; Gideon Gross; F Susan Wong
Journal:  J Immunol Methods       Date:  2015-01-17       Impact factor: 2.303

8.  Prolonged Exposure to Insulin Inactivates Akt and Erk1/2 and Increases Pancreatic Islet and INS1E β-Cell Apoptosis.

Authors:  Nadia Rachdaoui; Luis Polo-Parada; Faramarz Ismail-Beigi
Journal:  J Endocr Soc       Date:  2018-11-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.